REDUCTION IN CONTROLLED ATTENUATION PARAMETER AND LIVER STIFFNESS WITH SAROGLITAZAR IN NAFLD: A PROSPECTIVE ANALYSIS. Int. Res. J. Pharm. 2025, 16 (2), 38-49. https://doi.org/10.56802/y0zhqk37.